» Authors » Allison S Cohen

Allison S Cohen

Explore the profile of Allison S Cohen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 621
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciombor K, Bae S, Whisenant J, Ayers G, Sheng Q, Peterson T, et al.
Clin Cancer Res . 2025 Feb; PMID: 39927885
Purpose: EGFR-targeting monoclonal antibodies are essential for managing RAS WT metastatic colorectal cancer (mCRC), but their limited efficacy necessitates exploring immunological and metabolic factors influencing response. This study evaluated glutamine...
2.
Ayers G, Cohen A, Bae S, Wen X, Pollard A, Sharma S, et al.
PLoS One . 2025 Jan; 20(1):e0313123. PMID: 39787098
Introduction: Measurement of repeatability and reproducibility (R&R) is necessary to realize the full potential of positron emission tomography (PET). Several studies have evaluated the reproducibility of PET using 18F-FDG, the...
3.
Huynh A, Cohen A, Doligalski M, Casagni T, Moberg V, Huang X, et al.
Cancer Res Commun . 2024 Sep; 4(11):2877-2887. PMID: 39320054
Significance: Human TLR2 is broadly expressed among pancreatic adenocarcinomas, and the highly specific TLR2L-800 fluorescence molecular imaging agent has potential for use in fluorescence-guided surgery to increase R0 margins and...
4.
Gammon S, Cohen A, Lehnert A, Sullivan D, Malyarenko D, Manning H, et al.
Tomography . 2023 Apr; 9(2):750-758. PMID: 37104131
Providing method descriptions that are more detailed than currently available in typical peer reviewed journals has been identified as an actionable area for improvement. In the biochemical and cell biology...
5.
Bae S, Wang J, Georgiou D, Wen X, Cohen A, Geng L, et al.
Tomography . 2023 Mar; 9(2):497-508. PMID: 36961000
Early response assessment is critical for personalizing cancer therapy. Emerging therapeutic regimens with encouraging results in the wild-type (WT) colorectal cancer (CRC) setting include inhibitors of epidermal growth factor receptor...
6.
Lin M, Coll R, Cohen A, Georgiou D, Manning H
Molecules . 2022 Oct; 27(20). PMID: 36296381
Molecular imaging is the visual representation of biological processes that take place at the cellular or molecular level in living organisms. To date, molecular imaging plays an important role in...
7.
Cohen A, Grudzinski J, Smith G, Peterson T, Whisenant J, Hickman T, et al.
J Nucl Med . 2021 May; 63(1):36-43. PMID: 33931465
Altered metabolism is a hallmark of cancer. In addition to glucose, glutamine is an important nutrient for cellular growth and proliferation. Noninvasive imaging via PET may help facilitate precision treatment...
8.
Reinfeld B, Madden M, Wolf M, Chytil A, Bader J, Patterson A, et al.
Nature . 2021 Apr; 593(7858):282-288. PMID: 33828302
Cancer cells characteristically consume glucose through Warburg metabolism, a process that forms the basis of tumour imaging by positron emission tomography (PET). Tumour-infiltrating immune cells also rely on glucose, and...
9.
Cohen A, Li J, Hight M, McKinley E, Fu A, Payne A, et al.
Clin Cancer Res . 2020 Sep; 26(22):5914-5925. PMID: 32933996
Purpose: Pancreatic cancer is among the most aggressive malignancies and is rarely discovered early. However, pancreatic "incidentalomas," particularly cysts, are frequently identified in asymptomatic patients through anatomic imaging for unrelated...
10.
Cohen A, Geng L, Zhao P, Fu A, Schulte M, Graves-Deal R, et al.
Transl Oncol . 2020 Jul; 13(10):100828. PMID: 32652471
Improving response to epidermal growth factor receptor (EGFR)-targeted therapies in patients with advanced wild-type (WT) RAS colorectal cancer (CRC) remains an unmet need. In this preclinical work, we evaluated a...